How much exercise is needed for maximum heart benefit?February 5, 2020Preventive CareCAD & AtherosclerosisLipid DisordersDiabetes
Statin, antihypertensive treatment don’t guarantee healthier lifestylesFebruary 5, 2020HypertensionCAD & AtherosclerosisPreventive CareLipid Disorders
Silent ischemia isn’t what it used to beJanuary 30, 2020CAD & AtherosclerosisInterventional Cardiology & Surgery
What 2019’s top five CAD trials tell usJanuary 29, 2020Interventional Cardiology & SurgeryCAD & AtherosclerosisThrombosis
FFR use nearly halved 1-year mortality risk in ischemic heart diseaseJanuary 27, 2020Interventional Cardiology & SurgeryCAD & Atherosclerosis
New Vascepa indication opens up treatment to millions; “Most significant event since statins”January 24, 2020Lipid DisordersCAD & AtherosclerosisPreventive Care
Redo PCI or CABG, left main patients pay a price: EXCELJanuary 22, 2020Interventional Cardiology & SurgeryCAD & Atherosclerosis
Why STEMI patients benefit from PCI of nonculprit lesionsJanuary 22, 2020Interventional Cardiology & SurgeryAcute Coronary SyndromesCAD & Atherosclerosis
Cardiovascular risks associated with cannabis useJanuary 20, 2020Preventive CareAcute Coronary SyndromesArrhythmias & EPStrokeHeart FailureCAD & AtherosclerosisInterventional Cardiology & Surgery
Coronary function testing during angiography boosts 1-year angina outcomesJanuary 15, 2020Interventional Cardiology & SurgeryCAD & Atherosclerosis
Icosapent ethyl approved for cardiovascular risk reductionDecember 13, 2019Lipid DisordersCAD & AtherosclerosisPreventive Care
Lp(a) molar concentration flags CVD, diabetes riskDecember 9, 2019CAD & AtherosclerosisLipid Disorders
Colchicine pre-PCI improves biomarkers, not injury riskDecember 5, 2019Interventional Cardiology & SurgeryCAD & Atherosclerosis
Icosapent ethyl cost effective in REDUCE-IT analysisDecember 2, 2019CAD & AtherosclerosisLipid DisordersPreventive Care
